Two of four experimental Ebola drugs being tested in Congo appear to be saving lives, international health authorities announce.
Two of four experimental Ebola drugs being tested in Congo seem to be saving lives, international health authorities announced Monday.
The two drugs — one developed by Regeneron Pharmaceuticals and the other by NIH researchers — are antibodies that work by blocking the virus. On Friday, independent study monitors reviewed how the first several hundred patients in the Congo study were faring — and found enough difference to call an early halt to the trial. The panel determined that the Regeneron compound clearly was working better than the rest, and the NIH antibody wasn't far behind, Fauci explained. Next, researchers will do further study to nail down how well those two compounds work.
Tackling Congo's outbreak has been complicated both by conflict in the region and because many people don't believe Ebola is real and choose to stay at home when they're sick, which spurs spread of the virus.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Scientists hail promise of first effective Ebola treatments in Congo trialScientists are a step closer to finding the first effective treatments for the d...
Read more »
Two experimental Ebola treatments being tested in Congo show promiseOutbreak of the virus spreading in eastern Democratic Republic of Congo since August 2018 is the world's second largest in history.
Read more »
Ebola now curable after trials of drugs in DRC, say scientistsCongo results show good survival rates for patients treated quickly with antibodies. Ebola can no longer be called an incurable disease, scientists have said, after two of four drugs being trialled in the major outbreak in the Democratic Republic of the Congo were found to have significantly reduced
Read more »
WHO says no new Ebola cases in Goma, vaccinates over 1,300The World Health Organisation has vaccinated over 1,300 people who potentially c...
Read more »